Literature DB >> 12368903

Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin.

Rajesh Ramachandran1, Alejandro P Heuck, Rodney K Tweten, Arthur E Johnson.   

Abstract

Perfringolysin O (PFO), a cytolytic toxin secreted by pathogenic Clostridium perfringens, forms large pores in cholesterol-containing membranes. Domain 4 (D4) of the protein interacts first with the membrane and is responsible for cholesterol recognition. By using several independent fluorescence techniques, we have determined the topography of D4 in the membrane-inserted oligomeric form of the toxin. Only the short hydrophobic loops at the tip of the D4 beta-sandwich are exposed to the bilayer interior, whereas the remainder of D4 projects from the membrane surface and is surrounded by water, making little or no contact with adjacent protein monomers in the oligomer. Thus, a limited interaction of D4 with the bilayer core seems to be sufficient to accomplish cholesterol recognition and initial binding of PFO to the membrane. Furthermore, D4 serves as the fulcrum around which extensive structural changes occur during the formation and insertion of the large transmembrane beta-barrel into the bilayer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368903     DOI: 10.1038/nsb855

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  76 in total

1.  The solution structure and oligomerization behavior of two bacterial toxins: pneumolysin and perfringolysin O.

Authors:  Alexandra S Solovyova; Marcelo Nöllmann; Timothy J Mitchell; Olwyn Byron
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

2.  Monomer-monomer interactions propagate structural transitions necessary for pore formation by the cholesterol-dependent cytolysins.

Authors:  Eileen M Hotze; Elizabeth Wilson-Kubalek; Allison J Farrand; Lori Bentsen; Michael W Parker; Arthur E Johnson; Rodney K Tweten
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

Review 3.  Membrane assembly of the cholesterol-dependent cytolysin pore complex.

Authors:  Eileen M Hotze; Rodney K Tweten
Journal:  Biochim Biophys Acta       Date:  2011-07-31

4.  Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.

Authors:  Lea-Ann S Kirkham; Johanna M C Jefferies; Alison R Kerr; Yu Jing; Stuart C Clarke; Andrew Smith; Tim J Mitchell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

5.  Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin.

Authors:  Galina Polekhina; Kara Sue Giddings; Rodney K Tweten; Michael W Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-06       Impact factor: 11.205

6.  The domains of a cholesterol-dependent cytolysin undergo a major FRET-detected rearrangement during pore formation.

Authors:  Rajesh Ramachandran; Rodney K Tweten; Arthur E Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-06       Impact factor: 11.205

Review 7.  Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins.

Authors:  Rodney K Tweten
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

8.  Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis.

Authors:  Stephanie LaChapelle; Rodney K Tweten; Eileen M Hotze
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

9.  Cholesterol exposure at the membrane surface is necessary and sufficient to trigger perfringolysin O binding.

Authors:  John J Flanagan; Rodney K Tweten; Arthur E Johnson; Alejandro P Heuck
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

10.  Hydramacin-1 in action: scrutinizing the barnacle model.

Authors:  Matthias Michalek; Bruno Vincent; Rainer Podschun; Joachim Grötzinger; Burkhard Bechinger; Sascha Jung
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.